111 related articles for article (PubMed ID: 11214876)
1. Automation of the synthesis of highly concentrated 188Re-MAG3 for intracoronary radiation therapy.
Oh SJ; Moon DH; Ha HJ; Park SW; Hong MK; Park SJ; Choi TH; Lim SM; Choi CW; Knapp FF; Lee HK
Appl Radiat Isot; 2001 Mar; 54(3):419-27. PubMed ID: 11214876
[TBL] [Abstract][Full Text] [Related]
2. Endovascular beta irradiation for prevention of restenosis using solution radioisotopes: pharmacologic and dosimetric properties of rhenium-188 compounds.
Knapp FF; Guhlke S; Beets AL; Lin WY; Stabin M; Amols H; Weinberger J
Cardiovasc Radiat Med; 1999; 1(1):86-97. PubMed ID: 11272362
[TBL] [Abstract][Full Text] [Related]
3. 188Re-ethylene dicysteine: a novel agent for possible use in endovascular radiation therapy.
Das T; Banerjee S; Samuel G; Sarma HD; Ramamoorthy N; Pillai MR
Nucl Med Commun; 2000 Oct; 21(10):939-45. PubMed ID: 11130335
[TBL] [Abstract][Full Text] [Related]
4. Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies.
Blower PJ; Lam AS; O'Doherty MJ; Kettle AG; Coakley AJ; Knapp FF
Eur J Nucl Med; 1998 Jun; 25(6):613-21. PubMed ID: 9618576
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of three rhenium-188 candidates for intravascular radiation therapy with liquid-filled balloons to prevent restenosis.
Lin WY; Tsai SC; Hsieh BT; Lee TW; Ting G; Wang SJ
J Nucl Cardiol; 2000; 7(1):37-42. PubMed ID: 10698233
[TBL] [Abstract][Full Text] [Related]
6. Extra-stent vascular remodeling in in-stent restenosis after 188Re-MAG3 radiation therapy.
Hong MK; Park SW; Moon DH; Oh SJ; Lee CW; Kim YH; Kim JH; Zhang Y; Song JM; Kang DH; Song JK; Kim JJ; Park SJ
Int J Cardiol; 2003 Dec; 92(2-3):187-91. PubMed ID: 14659852
[TBL] [Abstract][Full Text] [Related]
7. Radiolabelling morpholinos with 188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation.
He J; Liu C; Vanderheyden JL; Liu G; Dou S; Rusckowski M; Hnatowich DJ
Nucl Med Commun; 2004 Jul; 25(7):731-6. PubMed ID: 15208502
[TBL] [Abstract][Full Text] [Related]
8. Leakage of a liquid 188Re-filled balloon system during intracoronary brachytherapy. A case report.
Hausleiter J; Li A; Makkar R; Berman D; Robinson A; Litvack F; Eigler N; Whiting J
Cardiovasc Radiat Med; 2000; 2(1):7-10. PubMed ID: 11229063
[TBL] [Abstract][Full Text] [Related]
9. Dosimetry of rhenium-188 diethylene triamine penta-acetic acid for endovascular intra-balloon brachytherapy after coronary angioplasty.
Lee J; Lee DS; Kim KM; Yeo JS; Cheon GJ; Kim SK; Ahn JY; Jeong JM; Chung JK; Lee MC
Eur J Nucl Med; 2000 Jan; 27(1):76-82. PubMed ID: 10654151
[TBL] [Abstract][Full Text] [Related]
10. [Production and therapeutic use of rhenium-186, 188--the future of radionuclides].
Vucina J; Han R
Med Pregl; 2003; 56(7-8):362-5. PubMed ID: 14587255
[TBL] [Abstract][Full Text] [Related]
11. Development of a rhenium-186-labeled MAG3-conjugated bisphosphonate for the palliation of metastatic bone pain based on the concept of bifunctional radiopharmaceuticals.
Ogawa K; Mukai T; Arano Y; Ono M; Hanaoka H; Ishino S; Hashimoto K; Nishimura H; Saji H
Bioconjug Chem; 2005; 16(4):751-7. PubMed ID: 16029015
[TBL] [Abstract][Full Text] [Related]
12. Dosimetry in leakage of (188)Re-DTPA during intracoronary balloon brachytherapy.
Paeng JC; Lee DS; Kang WJ; Yang HM; Chung JK; Jeong JM; Chae IH; Lee MM; Lee MC
Eur J Nucl Med Mol Imaging; 2003 Sep; 30(9):1263-5. PubMed ID: 12811423
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of 99Tcm-pertechnetate and 188Re-perrhenate after oral administration of perchlorate: option for subsequent care after the use of liquid 188Re in a balloon catheter.
Kotzerke J; Fenchel S; Guhlmann A; Stabin M; Rentschler M; Knapp FF; Reske SN
Nucl Med Commun; 1998 Aug; 19(8):795-801. PubMed ID: 9751935
[TBL] [Abstract][Full Text] [Related]
14. Rhenium-188--a generator-derived radioisotope for cancer therapy.
Knapp FF
Cancer Biother Radiopharm; 1998 Oct; 13(5):337-49. PubMed ID: 10851424
[TBL] [Abstract][Full Text] [Related]
15. Automated preparation of 188Re-labeled radiopharmaceuticals for endovascular radiation therapy.
Oh SJ; Moon DH; Lee WW; Park SW; Hong MK; Park SJ; Shin DI; Lee HK
Appl Radiat Isot; 2003 Oct; 59(4):225-30. PubMed ID: 14522229
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes after treatment of diffuse in-stent restenosis with rotational atherectomy followed by beta-radiation therapy with a 188Re-MAG3-filled balloon.
Lee SW; Park SW; Hong MK; Kim YH; Lee JH; Park JH; Moon DH; Oh SJ; Lee CW; Kim JJ; Park SJ
Int J Cardiol; 2005 Mar; 99(2):201-5. PubMed ID: 15749176
[TBL] [Abstract][Full Text] [Related]
17. Treatment of diffuse in-stent restenosis with rotational atherectomy followed by radiation therapy with a rhenium-188-mercaptoacetyltriglycine-filled balloon.
Park SW; Hong MK; Moon DH; Oh SJ; Lee CW; Kim JJ; Park SJ
J Am Coll Cardiol; 2001 Sep; 38(3):631-7. PubMed ID: 11527608
[TBL] [Abstract][Full Text] [Related]
18. Rhenium-188: availability from the (188)W/(188)Re generator and status of current applications.
Pillai MR; Dash A; Knapp FF
Curr Radiopharm; 2012 Jul; 5(3):228-43. PubMed ID: 22642385
[TBL] [Abstract][Full Text] [Related]
19. Comparison of angiographic and clinical outcomes between rotational atherectomy versus balloon angioplasty followed by radiation therapy with a rhenium-188-mercaptoacetyltriglycine-filled balloon in the treatment of diffuse in-stent restenosis.
Lee SW; Park SW; Hong MK; Lee JH; Kim YH; Moon DH; Oh SJ; Lee CW; Kim JJ; Park SJ
Int J Cardiol; 2005 Jul; 102(2):179-85. PubMed ID: 15982482
[TBL] [Abstract][Full Text] [Related]
20. Incidence and predictors of late recurrence after beta-radiation therapy with a 188Re-MAG3-filled balloon for diffuse in-stent restenosis.
Lee SW; Park SW; Hong MK; Kim YH; Han KH; Kim J; Park JH; Oh SJ; Moon DH; Oh SJ; Lee CW; Kim JJ; Park SJ
Am Heart J; 2006 Jan; 151(1):158-63. PubMed ID: 16368310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
